-
Research ethics: Not applicable.
-
Informed consent: Not applicable.
-
Author contributions: The author has accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: Eleftherios Diamandis holds an advisory and consultation role with Abbott Diagnostics.
-
Research funding: None declared.
-
Data availability: Not applicable.
References
1. Plebani, M. ChatGPT: Angel or Demond? Critical thinking is still needed. Clin Chem Lab Med 2023;61:1131–2. https://doi.org/10.1515/cclm-2023-0387.Search in Google Scholar PubMed
2. Fernandes, AC, Souto, MEVC. Benefits, limits, and risks of GPT-4 as an AI Chatbot for medicine. N Engl J Med 2023;388:2399–400. https://doi.org/10.1056/NEJMc2305286.Search in Google Scholar PubMed
© 2023 Walter de Gruyter GmbH, Berlin/Boston